Webinar Announcement: In Vitro Assessment of Endocrine Disruptors: Insights & Developments
June 08, 2020
We have developed the sodium–iodide symporter (NIS) as one of our latest newly developed assays. To learn more about this transporter that is used in endocrine disruptors safety testing we would like to invite you to join us to the next free Webinar organized by our parent company, Charles River Laboratories:
Title of the Webinar: In Vitro Assessment of Endocrine Disruptors: Insights & Developments
Date: Thursday, June 11, 2020
11:00 AM - 12:00 PM EDT (5:00 PM - 6:00 PM CEST)
Presenter: Jeroen Rijk, Phd, Study Director, In vitro DMPK, Charles River
Join us for an in-depth exploration of guideline assays that allow us to assess endocrine disruption in vitro. After this second webinar, you’ll know where these assays fit into the endocrine disruptor framework and have a better understanding of the practical aspects of study performance and interpretation of results.
Finally, we will share some new developments in this arena, such as in vitro assays to evaluate disruption of the thyroid hormone pathway.
Here you can watch the other Webinars in the series and register for the next one!
Next entry: Announcement of the Meet the Experts Transporter Webinar Series!
Previous entry: Webinar Announcement: The Next Frontier in ADME Science: Predicting and Verifying Tissue Drug Exposure
